Health
‘Not enough evidence’: Key taskforce rejects rollout of new COVID-19 drug – Sydney Morning Herald
A national taskforce says it cannot yet support the use of new treatment Sotrovimab, of which the federal government recently…
The governments purchase was supported by the federal governments science and industry technical advisory group, Mr Hunt said in a statement.
The taskforces recommendation was prior to the current assessment of Sotrovimab by the TGA, a spokesman for the…
Continue Reading
-
General13 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business20 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
Business24 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM